Epigenetics of Homocystinuria, Hydrogen Sulfide, and Circadian Clock Ablation in Cardiovascular-Renal Disease

被引:0
|
作者
Tyagi, Suresh C. [1 ]
机构
[1] Univ Louisville, Sch Med, Dept Physiol, Louisville, KY 40202 USA
关键词
folate 1-carbon metabolism; heart failure; ATP-citrate lyase; gene writer; gene eraser and editor; Piezo; interoception; HFpEF; HFrEF; AKI; CKD; K-ATP CHANNEL; TRIGGERS MITOCHONDRIA DEGRADATION; ISCHEMIA-REPERFUSION INJURY; CYSTATHIONINE BETA-SYNTHASE; BLOOD-PRESSURE VARIATION; MATRIX METALLOPROTEINASES; TISSUE INHIBITORS; OXIDATIVE STRESS; HEART-FAILURE; DIASTOLIC DYSFUNCTION;
D O I
10.3390/cimb46120824
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Morning-time heart attacks are associated with an ablation in the sleep-time dip in blood pressure, the mechanism of which is unknown. The epigenetic changes are the hallmark of sleep and circadian clock disruption and homocystinuria (HHcy). The homocystinuria causes ablation in the dip in blood pressure during sleep. Interestingly, HHcy is generated during the epigenetic gene turning off and turning on (i.e., imprinting) by methylation of the DNA promoter. The mitochondrial sulfur metabolism by 3-mercaptopyruvate sulfur transferase (3MST), ATP citrate lyase (ACYL), and epigenetic rhythmic methylation are regulated by folate 1-carbon metabolism (FOCM), i.e., the methionine (M)-SAM-SAH-Hcy, adenosine, and uric acid cycle. Epigenetic gene writer (DNMT), gene eraser (TET/FTO), and editor de-aminase (ADAR) regulate the rhythmic, i.e., reversible methylation/demethylation of H3K4, H3K9, H4K20, m6A, and m5C. The mitochondrial ATP citrate cycle and creatine kinase (CK) regulate chromatin transcription, maturation, and accessibility as well as muscle function. The transcription is regulated by methylation. The maturation and accessibility are controlled by acetylation. However, it is unclear whether a high fat dysbiotic diet (HFD) causes dysrhythmic expression of the gene writer, eraser, and editor, creating hyperuricemia and cardiac and renal dysfunction. We hypothesized that an HFD increases the gene writer (DNMT1) and editor (ADAR), decreases the eraser (TET/FTO), and increases uric acid to cause chronic diseases. This increases the levels of H3K4, H3K9, H4K20, m6A, and m5C. Interestingly, the DNMT1KO mitigates. Further, the DNMT1KO and ADAR inhibition attenuate HFD-induced NGAL/FGF23/TMPRSS2/MMP2, 9, 13, and uric acid levels and improve cardiac and renal remodeling. Although the novel role of nerve endings by the Piezo channels (i.e., the combination of ENaC, VDAC, TRPV, K+, and Mg2+ channels) in the interoception is suggested, interestingly, we and others have shown mechanisms independent of the nerve, by interoception, such as the cargo of the exosome in denervation models of heart failure. If proper and appropriate levels of these enzymes are available to covert homocysteine to hydrogen sulfide (H2S) during homocystinuria, then the H2S can potentially serve as a newer form of treatment for morning heart attacks and renal sulfur transsulfuration transport diseases.
引用
收藏
页码:13783 / 13797
页数:15
相关论文
共 50 条
  • [31] The roles of hydrogen sulfide in renal physiology and disease states
    Feng, Jianan
    Lu, Xiangxue
    Li, Han
    Wang, Shixiang
    RENAL FAILURE, 2022, 44 (01) : 1289 - 1308
  • [32] Hydrogen sulfide in renal physiology, disease and transplantation - The smell of renal protection
    Koning, Anne M.
    Frenay, Anne-Roos S.
    Leuvenink, Henri G. D.
    van Goor, Harry
    NITRIC OXIDE-BIOLOGY AND CHEMISTRY, 2015, 46 : 37 - 49
  • [33] Circadian Blood Pressure Rhythm in Cardiovascular and Renal Health and Disease
    Zhang, Jiayang
    Sun, Ruoyu
    Jiang, Tingting
    Yang, Guangrui
    Chen, Lihong
    BIOMOLECULES, 2021, 11 (06)
  • [34] Fighting Oxidative Stress with Sulfur: Hydrogen Sulfide in the Renal and Cardiovascular Systems
    Scammahorn, Joshua J.
    Nguyen, Isabel T. N.
    Bos, Eelke M.
    Van Goor, Harry
    Joles, Jaap A.
    ANTIOXIDANTS, 2021, 10 (03) : 1 - 21
  • [35] Development of Hydrogen Sulfide-Based Therapeutics for Cardiovascular Disease
    Benjamin L. Predmore
    David J. Lefer
    Journal of Cardiovascular Translational Research, 2010, 3 : 487 - 498
  • [36] Development of Hydrogen Sulfide-Based Therapeutics for Cardiovascular Disease
    Predmore, Benjamin L.
    Lefer, David J.
    JOURNAL OF CARDIOVASCULAR TRANSLATIONAL RESEARCH, 2010, 3 (05) : 487 - 498
  • [37] Harnessing the Benefits of Endogenous Hydrogen Sulfide to Reduce Cardiovascular Disease
    Casin, Kevin M.
    Calvert, John W.
    ANTIOXIDANTS, 2021, 10 (03) : 1 - 20
  • [38] Uric acid and cardiovascular-renal disease risk. Insights from a human model opposite to hypertension
    Maiolino, Giuseppe
    Pagnin, Elisa
    Plebani, Mario
    Davis, Paul A.
    Calo, Lorenzo A.
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2016, 212 : 18 - 19
  • [39] Disrupting the key circadian regulator CLOCK leads to age-dependent cardiovascular disease
    Alibhai, Faisal J.
    LaMarre, Jonathan
    Reitz, Cristine J.
    Tsimakouridze, Elena V.
    Kroetsch, Jeffrey T.
    Bolz, Steffen-Sebastian
    Shulman, Alex
    Steinberg, Samantha
    Burris, Thomas P.
    Oudit, Gavin Y.
    Martino, Tami A.
    JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2017, 105 : 24 - 37
  • [40] CARDIOVASCULAR-RENAL REMODELING IN FABRY DISEASE: POSSIBLE INVOLVEMENT OF OXIDATIVE STRESS. A MOLECULAR BIOLOGY APPROACH
    Ravarotto, Verdiana
    Carraro, Gianni
    Bertoldi, Giovanni
    Alessi, Marianna
    Muraro, Eva
    Calo, Lorenzo
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2018, 33